Medify Solutions Ltd.

Medify Solutions Limited Announces Worldwide Partnership Status With Oracle

Toronto, Canada (ots/PRNewswire) - Remote Technology Company Medify Solutions is delighted to announce its worldwide partnership status with Oracle, the world's largest enterprise software company. The status will associate all Medify Group subsidiaries into the partnership, encompassing the planned group expansion and building on the collaboration. Jonathan Bryant, Group Executive Chairman of Medify Solutions, said: "I am absolutely delighted in releasing this news which is based on the developments and progress that the company has made. This is a fantastic start to the planned expansion of the company into the global market with news on Europe and the UK to follow." This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward- looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events. ots Originaltext: Medify Solutions Ltd. Im Internet recherchierbar: Contact: For further information: Medify Press Office:

Das könnte Sie auch interessieren: